Bolt Biotherapeutics, Inc. (BOLT) vs Traws Pharma, Inc. (TRAW)
Bolt Biotherapeutics, Inc. and Traws Pharma, Inc. are both Biotechnology companies. Bolt Biotherapeutics, Inc. and Traws Pharma, Inc. are of similar size ($7.3M and $6.9M). Traws Pharma, Inc. grew revenue faster over the last twelve months: 1,159.3% against 12.8%. Traws Pharma, Inc. has the higher net margin (0.00% vs −611.5%) and the higher return on invested capital (0.00% vs −143.8%). Across the 17 metrics below, Traws Pharma, Inc. leads on 10 and Bolt Biotherapeutics, Inc. on 7.
Valuation
Profitability
| Metric | BOLT | TRAW | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (654.53%) | 0.00% | 0.00% |
| Net margin | (611.47%) | 0.00% | 0.00% |
| Free cash flow margin | (655.72%) | 0.00% | 0.00% |
| Return on equity | (111.65%) | (319.42%) | (57.72%) |
| Return on assets | (49.62%) | (117.35%) | (49.22%) |
| Return on invested capital | (143.75%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack